XOMA Corporation (XOMAP)
26.08
0.06 (0.23%)
At close: Apr 28, 2025, 3:50 PM
26.08
0.00%
After-hours: Apr 28, 2025, 04:00 PM EDT
Company Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific.
The company engages in helping biotech companies for enhancing human health.
It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.
The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners.
It has a portfolio with approximately 70 assets.
XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Corporation
| Country | United States |
| IPO Date | Dec 16, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Owen P. Hughes Jr. |
Advertisement
Contact Details
Address: 2200 Powell Street EmeryVille, California United States | |
| Website | https://www.xoma.com |
Stock Details
| Ticker Symbol | XOMAP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000791908 |
| CUSIP Number | 98419J305 |
| ISIN Number | US98419J3059 |
| Employer ID | 52-2154066 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Owen P. Hughes Jr. | Chief Executive Officer & Director |
| Thomas M. Burns | Senior Vice President of Finance & Chief Financial Officer |
| Bradley Sitko | Chief Investment Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2025 | ARS | Filing |
| Apr 15, 2025 | DEF 14A | Filing |
| Apr 09, 2025 | 4 | Filing |
| Apr 07, 2025 | 4 | Filing |
| Apr 04, 2025 | PRE 14A | Filing |
| Apr 02, 2025 | 4 | Filing |
| Apr 02, 2025 | 4 | Filing |
| Mar 25, 2025 | 4 | Filing |
| Mar 17, 2025 | 10-K | Annual Report |
| Mar 17, 2025 | 8-K | Current Report |